Aier Eye Hospital Group (300015) - Total Assets
Based on the latest financial reports, Aier Eye Hospital Group (300015) holds total assets worth CN¥36.58 Billion CNY (≈ $5.35 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Aier Eye Hospital Group (300015) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Aier Eye Hospital Group - Total Assets Trend (2006–2025)
This chart illustrates how Aier Eye Hospital Group's total assets have evolved over time, based on quarterly financial data. See net assets of Aier Eye Hospital Group for net asset value and shareholders' equity analysis.
Aier Eye Hospital Group - Asset Composition Analysis
Current Asset Composition (December 2025)
Aier Eye Hospital Group's total assets of CN¥36.58 Billion consist of 27.5% current assets and 72.5% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 14.4% |
| Accounts Receivable | CN¥1.85 Billion | 5.0% |
| Inventory | CN¥980.79 Million | 2.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥1.03 Billion | 2.8% |
| Goodwill | CN¥9.49 Billion | 25.9% |
Asset Composition Trend (2006–2025)
This chart illustrates how Aier Eye Hospital Group's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Aier Eye Hospital Group worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aier Eye Hospital Group's current assets represent 27.5% of total assets in 2025, a decrease from 35.4% in 2006.
- Cash Position: Cash and equivalents constituted 14.4% of total assets in 2025, up from 11.7% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 27.0% of total assets, an increase from 0.0% in 2006.
- Asset Diversification: The largest asset category is goodwill at 25.9% of total assets.
Aier Eye Hospital Group Competitors by Total Assets
Key competitors of Aier Eye Hospital Group based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
FRESENIUS SE+CO. ADR 1/4
F:FREA
|
Germany | €41.40 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥18.84 Billion |
|
Sanbo Hospital Management Group Ltd. A
SHE:301293
|
China | CN¥3.72 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
RHOEN-KLINIK.UNSP.ADR 1/2
F:RHKU
|
Germany | €1.86 Billion |
|
Bait Bakfar Ltd
TA:BKFR
|
Israel | ILA2.25 Billion |
|
ARRAIL GROUP LTD.
F:I1D
|
Germany | €3.16 Billion |
|
Jack Nathan Medical Corp
V:JNH
|
Canada | CA$11.91 Million |
Aier Eye Hospital Group - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.44 | 1.62 | 1.24 |
| Quick Ratio | 1.29 | 1.48 | 1.15 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥3.10 Billion | CN¥4.12 Billion | CN¥1.44 Billion |
Aier Eye Hospital Group - Advanced Valuation Insights
This section examines the relationship between Aier Eye Hospital Group's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.40 |
| Latest Market Cap to Assets Ratio | 0.31 |
| Asset Growth Rate (YoY) | 10.3% |
| Total Assets | CN¥36.68 Billion |
| Market Capitalization | $11.54 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Aier Eye Hospital Group's assets below their book value (0.31x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Aier Eye Hospital Group's assets grew by 10.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Aier Eye Hospital Group (2006–2025)
The table below shows the annual total assets of Aier Eye Hospital Group from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥36.68 Billion ≈ $5.37 Billion |
+10.29% |
| 2024-12-31 | CN¥33.26 Billion ≈ $4.87 Billion |
+10.17% |
| 2023-12-31 | CN¥30.19 Billion ≈ $4.42 Billion |
+13.57% |
| 2022-12-31 | CN¥26.58 Billion ≈ $3.89 Billion |
+21.65% |
| 2021-12-31 | CN¥21.85 Billion ≈ $3.20 Billion |
+19.15% |
| 2020-12-31 | CN¥18.34 Billion ≈ $2.68 Billion |
+54.16% |
| 2019-12-31 | CN¥11.89 Billion ≈ $1.74 Billion |
+23.58% |
| 2018-12-31 | CN¥9.63 Billion ≈ $1.41 Billion |
+3.35% |
| 2017-12-31 | CN¥9.31 Billion ≈ $1.36 Billion |
+110.32% |
| 2016-12-31 | CN¥4.43 Billion ≈ $647.95 Million |
+35.97% |
| 2015-12-31 | CN¥3.26 Billion ≈ $476.55 Million |
+27.69% |
| 2014-12-31 | CN¥2.55 Billion ≈ $373.21 Million |
+20.37% |
| 2013-12-31 | CN¥2.12 Billion ≈ $310.05 Million |
+9.79% |
| 2012-12-31 | CN¥1.93 Billion ≈ $282.39 Million |
+12.08% |
| 2011-12-31 | CN¥1.72 Billion ≈ $251.96 Million |
+6.76% |
| 2010-12-31 | CN¥1.61 Billion ≈ $236.01 Million |
+14.23% |
| 2009-12-31 | CN¥1.41 Billion ≈ $206.61 Million |
+256.10% |
| 2008-12-31 | CN¥396.51 Million ≈ $58.02 Million |
+10.69% |
| 2007-12-31 | CN¥358.22 Million ≈ $52.42 Million |
+7.56% |
| 2006-12-31 | CN¥333.05 Million ≈ $48.74 Million |
-- |
About Aier Eye Hospital Group
Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, Europe, and Southeast Asia. It offers diagnosis and treatment of various ophthalmic diseases, surgical services, medical optometry, and lens fitting for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and p… Read more